Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferon.
| Image |  |
|---|---|
| Description | scientific article published on 15 February 2017 |
| Author/s |
author: Nobuharu Tamaki |
| Publication date | March 20, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |